Perspective Therapeutics, Inc.CATXNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-15.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-350.88%
202450.44%
2023-203.26%
2022-57.87%
2021-171.77%
202022.08%
201927.89%
201811.61%
20170.00%
2016-47.06%